Stockreport

How The Maravai LifeSciences (MRVI) Story Is Shifting As Analysts Rework Fair Value Targets [Yahoo! Finance]

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF Maravai LifeSciences Holdings is back in focus after analysts reset their price target around US$3, aligning it more closely with a refreshed model fair value of US$4.3 [Read more]